Literature DB >> 24668659

Skeletal dysplasia, global developmental delay, and multiple congenital anomalies in a 5-year-old boy-report of the second family with B3GAT3 mutation and expansion of the phenotype.

Julia E von Oettingen1, Wen-Hann Tan, Andrew Dauber.   

Abstract

As a major component of the extracellular matrix, proteoglycans influence the mechanical properties of connective tissue and play an important role in cell-cell and cell-matrix interactions. Genetic defects of proteoglycan biosynthesis lead to multi-system disorders, often most prominently affecting the skeletal system and skin. Specific deficiencies in the enzymes involved in the biosynthesis of the linkage region between the core of the proteoglycan protein and its glycosaminoglycan side chains are known as linkeropathies. We report on a patient from a second family with a homozygous c.830G>A (p.Arg277Gln) mutation in the B3GAT3 gene. The clinical features expand the previously reported phenotype of B3GAT3 mutations and of linkeropathies in general. This patient has short stature, facial dysmorphisms, skeletal findings, joint laxity, and cardiac manifestations similar to those previously associated with B3GAT3 mutations. However, he also has developmental delay, a refractive errors, dental defects, pectus carinatum, and skin abnormalities that have only been associated with linkeropathies caused by mutations in B4GALT6 and B4GALT7. He has bilateral inguinal hernias and atlanto-axial as well as atlanto-occipital instability that have not been previously associated with B3GAT3 mutations. We provide a detailed clinical report and a comparative overview of the phenotypic features of the linkeropathies caused by mutations in B3GAT3, B4GALT6, and B4GALT7.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  B3GAT3; Larsen-like syndrome; linkeropathy; proteoglycan disorder

Mesh:

Substances:

Year:  2014        PMID: 24668659      PMCID: PMC4384644          DOI: 10.1002/ajmg.a.36487

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  19 in total

Review 1.  Specificities of heparan sulphate proteoglycans in developmental processes.

Authors:  N Perrimon; M Bernfield
Journal:  Nature       Date:  2000-04-13       Impact factor: 49.962

Review 2.  Functions of cell surface heparan sulfate proteoglycans.

Authors:  M Bernfield; M Götte; P W Park; O Reizes; M L Fitzgerald; J Lincecum; M Zako
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

Review 3.  Order out of chaos: assembly of ligand binding sites in heparan sulfate.

Authors:  Jeffrey D Esko; Scott B Selleck
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

Review 4.  Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate.

Authors:  Kazuyuki Sugahara; Tadahisa Mikami; Toru Uyama; Souhei Mizuguchi; Kazuya Nomura; Hiroshi Kitagawa
Journal:  Curr Opin Struct Biol       Date:  2003-10       Impact factor: 6.809

5.  A genetic defect in the biosynthesis of dermatan sulfate proteoglycan: galactosyltransferase I deficiency in fibroblasts from a patient with a progeroid syndrome.

Authors:  E Quentin; A Gladen; L Rodén; H Kresse
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

Review 6.  Heparan sulphate proteoglycans: the sweet side of development.

Authors:  Udo Häcker; Kent Nybakken; Norbert Perrimon
Journal:  Nat Rev Mol Cell Biol       Date:  2005-07       Impact factor: 94.444

7.  Biosynthesis of chondroitin sulfate. Purification of UDP-D-xylose:core protein beta-D-xylosyltransferase by affinity chromatography.

Authors:  N B Schwartz; L Rodén
Journal:  Carbohydr Res       Date:  1974-10       Impact factor: 2.104

Review 8.  Redefining the progeroid form of Ehlers-Danlos syndrome: report of the fourth patient with B4GALT7 deficiency and review of the literature.

Authors:  Michael H Guo; Joan Stoler; Julian Lui; Ola Nilsson; Diana W Bianchi; Joel N Hirschhorn; Andrew Dauber
Journal:  Am J Med Genet A       Date:  2013-08-16       Impact factor: 2.802

Review 9.  Human genetic disorders caused by mutations in genes encoding biosynthetic enzymes for sulfated glycosaminoglycans.

Authors:  Shuji Mizumoto; Shiro Ikegawa; Kazuyuki Sugahara
Journal:  J Biol Chem       Date:  2013-03-01       Impact factor: 5.157

10.  Heparan sulfate biosynthesis enzymes EXT1 and EXT2 affect NDST1 expression and heparan sulfate sulfation.

Authors:  Jenny Presto; Maria Thuveson; Pernilla Carlsson; Marta Busse; Maria Wilén; Inger Eriksson; Marion Kusche-Gullberg; Lena Kjellén
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-12       Impact factor: 11.205

View more
  17 in total

1.  Skeletal dysplasia in a consanguineous clan from the island of Nias/Indonesia is caused by a novel mutation in B3GAT3.

Authors:  Birgit S Budde; Shuji Mizumoto; Ryo Kogawa; Christian Becker; Janine Altmüller; Holger Thiele; Franz Rüschendorf; Mohammad R Toliat; Gerrit Kaleschke; Johannes M Hämmerle; Wolfgang Höhne; Kazuyuki Sugahara; Peter Nürnberg; Ingo Kennerknecht
Journal:  Hum Genet       Date:  2015-04-19       Impact factor: 4.132

Review 2.  Biosynthesis of glycosaminoglycans: associated disorders and biochemical tests.

Authors:  Florin Sasarman; Catalina Maftei; Philippe M Campeau; Catherine Brunel-Guitton; Grant A Mitchell; Pierre Allard
Journal:  J Inherit Metab Dis       Date:  2015-12-21       Impact factor: 4.982

3.  A homozygous B3GAT3 mutation causes a severe syndrome with multiple fractures, expanding the phenotype of linkeropathy syndromes.

Authors:  Kelly L Jones; Ulrike Schwarze; Margaret P Adam; Peter H Byers; Heather C Mefford
Journal:  Am J Med Genet A       Date:  2015-06-18       Impact factor: 2.802

Review 4.  Cardiac complications of congenital disorders of glycosylation (CDG): a systematic review of the literature.

Authors:  D Marques-da-Silva; R Francisco; D Webster; V Dos Reis Ferreira; J Jaeken; T Pulinilkunnil
Journal:  J Inherit Metab Dis       Date:  2017-07-19       Impact factor: 4.982

Review 5.  Human genetic disorders and knockout mice deficient in glycosaminoglycan.

Authors:  Shuji Mizumoto; Shuhei Yamada; Kazuyuki Sugahara
Journal:  Biomed Res Int       Date:  2014-07-13       Impact factor: 3.411

6.  Functional validation of novel compound heterozygous variants in B3GAT3 resulting in severe osteopenia and fractures: expanding the disease phenotype.

Authors:  Florian Job; Shuji Mizumoto; Laurie Smith; Natario Couser; Ashley Brazil; Howard Saal; Melanie Patterson; Margaret I Gibson; Sarah Soden; Neil Miller; Isabelle Thiffault; Carol Saunders; Shuhei Yamada; Katrin Hoffmann; Kazuyuki Sugahara; Emily Farrow
Journal:  BMC Med Genet       Date:  2016-11-21       Impact factor: 2.103

7.  Novel Splicing Mutation in B3GAT3 Associated with Short Stature, GH Deficiency, Hypoglycaemia, Developmental Delay, and Multiple Congenital Anomalies.

Authors:  Samuel Bloor; Dinesh Giri; Mohammed Didi; Senthil Senniappan
Journal:  Case Rep Genet       Date:  2017-11-28

8.  B3GAT3-related disorder with craniosynostosis and bone fragility due to a unique mutation.

Authors:  Kevin Yauy; Frederic Tran Mau-Them; Marjolaine Willems; Christine Coubes; Patricia Blanchet; Christian Herlin; Ikram Taleb Arrada; Elodie Sanchez; Jean-Michel Faure; Marie-Pascale Le Gac; Olivier Prodhomme; Anne Boland; Vincent Meyer; Jean-Baptiste Rivière; Yannis Duffourd; Jean-François Deleuze; Thomas Guignard; Guillaume Captier; Mouna Barat-Houari; David Genevieve
Journal:  Genet Med       Date:  2017-08-03       Impact factor: 8.822

Review 9.  Chondrodysplasias With Multiple Dislocations Caused by Defects in Glycosaminoglycan Synthesis.

Authors:  Johanne Dubail; Valérie Cormier-Daire
Journal:  Front Genet       Date:  2021-06-16       Impact factor: 4.599

Review 10.  Mutations in Biosynthetic Enzymes for the Protein Linker Region of Chondroitin/Dermatan/Heparan Sulfate Cause Skeletal and Skin Dysplasias.

Authors:  Shuji Mizumoto; Shuhei Yamada; Kazuyuki Sugahara
Journal:  Biomed Res Int       Date:  2015-10-25       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.